PFAS Exposure Linked to Higher Nonmelanoma Skin Cancer Risk, Especially in Older Adults

Why It Matters

The association suggests that older Americans may face heightened skin‑cancer risk from PFDA, prompting urgent regulatory review and consumer‑level exposure mitigation.

Key Takeaways

• PFDA exposure doubles nonmelanoma skin cancer odds in adults 60+
• Mid-level PFDA tertile shows higher risk than low or high
• No significant link found for PFUnDA or PFOSA acetate
• Study used 44,790 NHANES adults, identifying 104 NMSC cases
• Results urge stricter PFAS monitoring and exposure controls

Pulse Analysis

Per‑ and polyfluoroalkyl substances (PFAS) have become ubiquitous in modern life. First introduced in the 1940s, these “forever chemicals” resist heat, water and oil, leading to their use in stain‑resistant textiles, cookware, firefighting foams and many industrial processes. In the United States, more than 6 million people are estimated to drink water that exceeds federal reporting thresholds, and PFAS are detectable in food, indoor dust and air. Their persistence raises chronic‑exposure concerns, especially as epidemiological work links them to immune dysfunction, metabolic disorders and now, potentially, skin cancer.

The new cross‑sectional analysis of eight NHANES cycles (2003‑2018) examined serum levels of three understudied PFAS—PFDA, PFUnDA and a PFOSA derivative—in 44,790 adults, of whom 104 reported physician‑diagnosed non‑melanoma skin cancer (NMSC). After adjusting for demographics, BMI and smoking, participants in the middle PFDA tertile faced a 73 % higher overall odds of NMSC, a risk that more than doubled (OR ≈ 2.3) among those aged 60 years or older. No comparable associations emerged for PFUnDA or the PFOSA compound, and the highest PFDA tertile did not show a clear trend, suggesting a non‑linear exposure‑response relationship.

These findings sharpen the call for tighter PFAS oversight. Regulators may need to revisit safe‑level benchmarks, especially for older populations who appear most vulnerable. The study’s reliance on self‑reported cancer diagnoses and its cross‑sectional design limit causal inference, underscoring the need for longitudinal cohorts and mechanistic research into PFDA‑induced oxidative stress in skin cells. Meanwhile, manufacturers face growing pressure to phase out PFDA‑containing formulations, and consumers can reduce personal exposure by selecting PFAS‑free products and using certified water‑filtration systems.